Production of gmp-compliant clinical amounts of copper-61 radiopharmaceuticals from liquid targets

HIGHLIGHTS

• who: Alexandra I. Fonseca and colleagues from the Lda, University of Coimbra have published the paper: Production of GMP-Compliant Clinical Amounts of Copper-61 Radiopharmaceuticals from Liquid Targets, in the Journal: Pharmaceuticals 2022, 723 of 22/04/2022
• what: The authors demonstrated that clinical amounts of 61 Cu-based radiopharmaceuticals can be produced, under GMP, in a medical cyclotron, using liquid targets.
• how: Radiochemical purity results indicated that these compounds are highly 12 h after the EOS.
• future: This work serves as background for future preclinical in_vitro and in_vivo studies . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.